Stockhead: ASX Tech Stocks: AnteoTech teams up with Trinseo for battery binding tech

AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech’s fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT). We are excited atRead more

AnteoTech broadens European market exposure, securing a Spanish and Portuguese Distribution Agreement for EuGeni AnteoTech is pleased to welcome another newly appointed distributor to the EuGeni family. Most recently, AnteoTech has appointed Vitro Master DiagnosticaRead more

AnteoTech is pleased to advise that it has renewed its contract with leading healthcare diagnostic partner Ellume Ltd. (“Ellume”) for the supply of AnteoBind to be used in Ellume’s range of tests. Ellume is anRead more

Australian-made RATs await TGA approval amid rapid antigen test shortage  Read more

With our energy labs now expanded to accommodate new equipment enabling us to continue our in-house validation and testing of AnteoX we are pleased to share Part 1 of a three-part series on how weRead more

Welcome to Part 2: Silicon anode coating, in our three-part series on how we make and test our Lithium-ion batteries here at AnteoTech. In this video, we create the anode by coating a copper currentRead more

The final video in our three-part series on how we make and test our Lithium-ion batteries is the Assembly of the Battery. Our testing for both the AnteoX Cross-Linker & Binder Program and the high-performanceRead more

AnteoTech Ltd is pleased to announce that its energy division and product AnteoX, have been recognised as an emerging leader at the 2022 Australian Technologies Competition (ATC). AnteoTech’s energy division which developed AnteoX, a uniqueRead more